Globus Medical, Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of Corporate Wrongdoing
NEW YORK, April 30, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating allegations for Globus Medical, Inc. shareholders (NYSE:GMED). Concerned GMED investors who purchased prior to April 22, 2015 are encouraged to contact securities attorney Hamilton Lindley by here.
On April 22, 2015, Globus Medical announced in a Securities and Exchange Commission ("SEC") filing that "[o]n April 16, 2015, KPMG LLP ("KPMG") orally notified Globus Medical that upon the completion of KPMG's review of the Company's consolidated financial statements for the quarterly reporting period ended March 31, 2015 and the filing of the related Quarterly Report on Form 10-Q, KPMG declines to stand for reelection as the independent registered public accounting firm for the Company. KPMG's decision was accepted by the audit committee of the Company's board of directors." On this news, share fell dramatically on April 23, 2015.
Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. GMED stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at [email protected] with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/GMED.
Find these Waco family law attorneys, Waco criminal defense attorneys and Waco personal injury lawyers on social media on Google+, LinkedIn, Facebook, and Twitter.
SOURCE Dunnam & Dunnam
Share this article